EU Launches €10 Billion Life Sciences Strategy to Lead by 2030
Summary:
The European Commission unveils an ambitious plan backed by €10 billion annually to become the world’s top life sciences hub, targeting innovation, market access, and public trust.
Biotech Industry Faces Perfect Storm of Funding and Regulatory Challenges
Summary:
Life sciences sector grapples with five-year funding drought and federal cuts despite FDA promises of collaboration, forcing companies to reassess operations.
NIH Suspends 40 Research Projects Over Gain-of-Function Concerns
Summary:
Federal agency halts dozens of pathogen studies following Trump executive order, puzzling scientists who question broad interpretation of safety risks.
Ultragenyx Gene Therapy Rejected by FDA Over Manufacturing Issues
Summary:
Rare disease treatment UX111 was denied approval due to facility concerns, though the company expects to resolve issues and resubmit within months for review.
Study Reveals Institution Location Drives 50% of Scientist Productivity
Summary:
Major research finds that where scientists work dramatically impacts output, with Boston-area researchers publishing 2-3 times more than peers elsewhere.
